Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May-Jun;16(3):310-316.
doi: 10.1097/ADM.0000000000000895.

Characterizing the Clinical use of a Novel Video-assisted Dosing Protocol With Secure Medication Dispensers to Reduce Barriers to Opioid Treatment

John R Brooklyn  1 , Marne Stothart, Mallory Stunell, Vanessa Melamede Berman, Danielle Rylant, Melanie Hanson
Affiliations

Characterizing the Clinical use of a Novel Video-assisted Dosing Protocol With Secure Medication Dispensers to Reduce Barriers to Opioid Treatment

John R Brooklyn et al. J Addict Med. 2022 May-Jun.

Abstract

Objectives: Distance and travel costs to opioid treatment programs (OTPs), especially in rural communities, are barriers to treatment for opioid use disorder. Retention rates at 12 months in our OTP are 55% (range 53%-61%).We piloted a novel treatment platform utilizing a video directly observed therapy (VDOT) smartphone app and a secure medication dispenser to support adherence with take-home doses of methadone or buprenorphine while enabling patients to maintain prosocial activities, reduce time and cost of travel, and increase retention.

Methods: Participants (n¼58) were adults in a Vermont OTP. Inclusion criteria included travel hardship, access to Wi-Fi or cellular network, and having an iPhone 4S or Android 4.0 or greater. Patients received a dispenser, VDOT app, clinic dispensed medication, counseling, and urine drug testing. Chart reviews assessed VDOT compliance, engagement in prosocial activities, travel costs and time savings, and treatment disposition/retention. Project-associated costs were examined.

Results: Of the 15,831 expected videos, 15,581 (98.4%) were received and only 10 (0.063%) showed signs of medication noncompliance with 1 (0.0064%) showing an overt attempt at diversion. About 93% of participants engaged in prosocial activities, travel time and costs were reduced 86%, median cost saved $72 weekly, median travel time saved 5.5 hours weekly and 98% of participants were in treatment 12 months later.

Conclusions: VDOT participants using dispensers showed high levels of medication ingestion integrity, had favorable clinical stability, and lower travel time and costs. These findings suggest that using VDOT with dispensers may hold promise as an innovative platform for supporting medication adherence.

PubMed Disclaimer

Conflict of interest statement

Dr. Brooklyn is a Medical Consultant for OpiSafe Denver, CO. Rest of the authors report no conflicts of interest.

References

    1. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Medication-Assisted Treatment for Opioid Use Disorder Study (MAT Study) [Web site], 2018a. Available at: https://www.cdc.gov/opioids/Medication-Assisted-Treatment-Opioid-Use-Dis... . Accessed November 3, 2018.
    1. Substance Abuse and Mental Health Services Administration (SAMHSA). 2017 National Survey on Drug Use and Health (NSDUH) Annual National Report [Web site] 2017a. Available at: https://www.samhsa.gov/data/report/2017-nsduh-annual-national-report . Accessed November 3, 2018.
    1. Centers for Disease Control and Prevention. Drug Overdose Death Data [Web site] 2018b. Available at: https://www.cdc.gov/drugoverdose/data/statedeaths.html . Accessed November 3, 2018.
    1. Sigmon S. The untapped potential of office-based buprenorphine treatment. JAMA Psychiatry . 2015;72(4):395–396.
    1. Rosenblatt R, Andrilla CH, Catlin M, et al. Geographic and specialty distribution of US physicians trained to treat opioid use disorder. Ann Fam Med . 2017;13(1):23–26.

Publication types